MarketBeat Instant News Alerts 2 hours agoWells Fargo & Company Cuts Pershing Square (NYSE:PS) Price Target to $34.00MarketBeatWells Fargo & Company cut their target price on Pershing Square from $37.00 to $34.00 and set an "equal weight" rating on the stock in a report on Monday.NYSE:PSRead Wells Fargo & Company Cuts Pershing Square (NYSE:PS) Price Target to $34.002 hours agoMurphy USA (NYSE:MUSA) Price Target Raised to $570.00 at Wells Fargo & CompanyMarketBeatWells Fargo & Company boosted their price target on shares of Murphy USA from $520.00 to $570.00 and gave the stock an "equal weight" rating in a research note on Monday.NYSE:MUSARead Murphy USA (NYSE:MUSA) Price Target Raised to $570.00 at Wells Fargo & Company2 hours agoWells Fargo & Company Issues Pessimistic Forecast for Genius Sports (NYSE:GENI) Stock PriceMarketBeatWells Fargo & Company cut their target price on shares of Genius Sports from $9.00 to $8.00 and set an "overweight" rating on the stock in a research note on Monday.NYSE:GENIRead Wells Fargo & Company Issues Pessimistic Forecast for Genius Sports (NYSE:GENI) Stock Price2 hours agoTarget (NYSE:TGT) Price Target Raised to $150.00 at GuggenheimMarketBeatGuggenheim increased their target price on Target from $145.00 to $150.00 and gave the stock a "buy" rating in a research report on Monday.NYSE:TGTRead Target (NYSE:TGT) Price Target Raised to $150.00 at Guggenheim2 hours agoWells Fargo & Company Issues Pessimistic Forecast for Flutter Entertainment (NYSE:FLUT) Stock PriceMarketBeatWells Fargo & Company lowered their price target on shares of Flutter Entertainment from $168.00 to $137.00 and set an "equal weight" rating on the stock in a research note on Monday.NYSE:FLUTRead Wells Fargo & Company Issues Pessimistic Forecast for Flutter Entertainment (NYSE:FLUT) Stock Price2 hours agoWells Fargo & Company Cuts DraftKings (NASDAQ:DKNG) Price Target to $29.00MarketBeatWells Fargo & Company dropped their price target on DraftKings from $32.00 to $29.00 and set an "overweight" rating on the stock in a research report on Monday.NASDAQ:DKNGRead Wells Fargo & Company Cuts DraftKings (NASDAQ:DKNG) Price Target to $29.00 Trending News1Intuitive Machines (NASDAQ:LUNR) Upgraded at Zacks Research2BlackBerry (NYSE:BB) Stock Price Down 8.9% - Should You Sell?3Rubrik (NYSE:RBRK) Trading Down 6.3% After Insider Selling4IonQ (NYSE:IONQ) Stock Price Down 6.6% - Here's Why5Barclays Issues Pessimistic Forecast for TELUS (TSE:T) Stock Price6NetApp (NASDAQ:NTAP) Stock Price Down 6.5% After Insider Selling7USA Rare Earth (NASDAQ:USAR) Shares Down 8.1% - Here's What Happened8SpaceX (NASDAQ:SPCX) Stock Price Down 3.1% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoRoyal Bank Of Canada Issues Positive Forecast for Fifth Third Bancorp (NASDAQ:FITB) Stock PriceMarketBeatNASDAQ:FITBRead Royal Bank Of Canada Issues Positive Forecast for Fifth Third Bancorp (NASDAQ:FITB) Stock Price2 hours agoIMAX (NYSE:IMAX) Given Buy Rating at Rosenblatt SecuritiesMarketBeatNYSE:IMAXRead IMAX (NYSE:IMAX) Given Buy Rating at Rosenblatt Securities2 hours agoMorgan Stanley Issues Positive Forecast for Archer Daniels Midland (NYSE:ADM) Stock PriceMarketBeatNYSE:ADMRead Morgan Stanley Issues Positive Forecast for Archer Daniels Midland (NYSE:ADM) Stock Price2 hours agoMorgan Stanley Issues Positive Forecast for Erasca (NASDAQ:ERAS) Stock PriceMarketBeatNASDAQ:ERASRead Morgan Stanley Issues Positive Forecast for Erasca (NASDAQ:ERAS) Stock Price2 hours agoPTC Therapeutics (NASDAQ:PTCT) Price Target Lowered to $93.00 at Wells Fargo & CompanyMarketBeatNASDAQ:PTCTRead PTC Therapeutics (NASDAQ:PTCT) Price Target Lowered to $93.00 at Wells Fargo & Company2 hours agoSusquehanna Issues Pessimistic Forecast for Intuit (NASDAQ:INTU) Stock PriceMarketBeatNASDAQ:INTURead Susquehanna Issues Pessimistic Forecast for Intuit (NASDAQ:INTU) Stock Price2 hours agoDatadog (NASDAQ:DDOG) Price Target Raised to $300.00 at OppenheimerMarketBeatNASDAQ:DDOGRead Datadog (NASDAQ:DDOG) Price Target Raised to $300.00 at Oppenheimer2 hours agoOppenheimer Forecasts Strong Price Appreciation for Dynatrace (NYSE:DT) StockMarketBeatNYSE:DTRead Oppenheimer Forecasts Strong Price Appreciation for Dynatrace (NYSE:DT) Stock2 hours agoCelldex Therapeutics (NASDAQ:CLDX) Given New $100.00 Price Target at GuggenheimMarketBeatNASDAQ:CLDXRead Celldex Therapeutics (NASDAQ:CLDX) Given New $100.00 Price Target at Guggenheim2 hours agoAnthem (NASDAQ:ANTX) Coverage Initiated by Analysts at GuggenheimMarketBeatNASDAQ:ANTXRead Anthem (NASDAQ:ANTX) Coverage Initiated by Analysts at Guggenheim2 hours agoNextEra Energy (NYSE:NEE) Price Target Lowered to $95.00 at BMO Capital MarketsMarketBeatNYSE:NEERead NextEra Energy (NYSE:NEE) Price Target Lowered to $95.00 at BMO Capital Markets2 hours agoBrainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Rating of "Buy" by AnalystsMarketBeatNASDAQ:BWAYRead Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) Given Consensus Rating of "Buy" by Analysts2 hours agoEnpro Inc. (NYSE:NPO) Given Consensus Recommendation of "Moderate Buy" by BrokeragesMarketBeatNYSE:NPORead Enpro Inc. (NYSE:NPO) Given Consensus Recommendation of "Moderate Buy" by Brokerages2 hours agoBrainsway (NASDAQ:BWAY) Coverage Initiated by Analysts at BTIG ResearchMarketBeatNASDAQ:BWAYRead Brainsway (NASDAQ:BWAY) Coverage Initiated by Analysts at BTIG Research2 hours agoKeefe, Bruyette & Woods Increases Commerce Bancshares (NASDAQ:CBSH) Price Target to $62.00MarketBeatNASDAQ:CBSHRead Keefe, Bruyette & Woods Increases Commerce Bancshares (NASDAQ:CBSH) Price Target to $62.002 hours ago4D Molecular Therapeutics (NASDAQ:FDMT) Receives "Buy" Rating from HC WainwrightMarketBeatNASDAQ:FDMTRead 4D Molecular Therapeutics (NASDAQ:FDMT) Receives "Buy" Rating from HC Wainwright2 hours agoHC Wainwright Reiterates "Neutral" Rating for Aardvark Therapeutics (NASDAQ:AARD)MarketBeatNASDAQ:AARDRead HC Wainwright Reiterates "Neutral" Rating for Aardvark Therapeutics (NASDAQ:AARD)2 hours agoAmylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $24.00MarketBeatNASDAQ:AMLXRead Amylyx Pharmaceuticals (NASDAQ:AMLX) Price Target Raised to $24.002 hours agoCrocs (NASDAQ:CROX) Stock Price Expected to Rise, Seaport Research Partners Analyst SaysMarketBeatNASDAQ:CROXRead Crocs (NASDAQ:CROX) Stock Price Expected to Rise, Seaport Research Partners Analyst Says2 hours agoTim Jones Purchases 40,000 Shares of ForViva (LON:FVA) StockMarketBeatLON:FVARead Tim Jones Purchases 40,000 Shares of ForViva (LON:FVA) Stock2 hours agoFidus Investment (NASDAQ:FDUS) Given "Market Perform" Rating at Keefe, Bruyette & WoodsMarketBeatNASDAQ:FDUSRead Fidus Investment (NASDAQ:FDUS) Given "Market Perform" Rating at Keefe, Bruyette & Woods2 hours agoKeefe, Bruyette & Woods Forecasts Strong Price Appreciation for Fifth Third Bancorp (NASDAQ:FITB) StockMarketBeatNASDAQ:FITBRead Keefe, Bruyette & Woods Forecasts Strong Price Appreciation for Fifth Third Bancorp (NASDAQ:FITB) Stock2 hours agoImmuneering (NASDAQ:IMRX) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysMarketBeatNASDAQ:IMRXRead Immuneering (NASDAQ:IMRX) Stock Price Expected to Rise, Needham & Company LLC Analyst Says2 hours agoIndependent Bank (NASDAQ:INDB) Price Target Lowered to $96.00 at Keefe, Bruyette & WoodsMarketBeatNASDAQ:INDBRead Independent Bank (NASDAQ:INDB) Price Target Lowered to $96.00 at Keefe, Bruyette & Woods Featured Articles and OffersWhy Abbott Laboratories Stock Is Suddenly Winning Back Wall StreetBy Thomas Hughes | July 16, 2026DOJ Admits It In Court—Your Cash Can Be Seized Without WarningFrom Priority Gold (Ad)The SK Hynix IPO and 2027’s AI Memory SqueezeBy Jeffrey Neal Johnson | July 13, 2026Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity YetBy Thomas Hughes | July 14, 2026Why Johnson & Johnson’s Earnings Dip Looks Like a Buying OpportunityBy Thomas Hughes | July 15, 2026Grid crisis threatens crash 62 times worse than Great DepressionFrom Altimetry (Ad)2 Quantum Stocks That Could Challenge IonQ’s LeadershipBy Nathan Reiff | July 15, 2026AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space SectorBy Jessica Mitacek | July 17, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 416 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
